about
Selective alpha7 nicotinic receptor activation by AZD0328 enhances cortical dopamine release and improves learning and attentional processes.Quantification of the interrelationships of receptor pharmacologies within a tricyclic privileged structural scaffold through application of modified forward selection.Quetiapine and its metabolite norquetiapine: translation from in vitro pharmacology to in vivo efficacy in rodent models.Preclinical pharmacology and pharmacokinetics of AZD3783, a selective 5-hydroxytryptamine 1B receptor antagonist.Absence of direct effects on the dopamine D2 receptor by mGluR2/3-selective receptor agonists LY 354,740 and LY 379,268.Lead retards development of Drosophila melanogaster.
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
D Widzowski
@ast
D Widzowski
@en
D Widzowski
@es
D Widzowski
@nl
Daniel Widzowski
@pl
type
label
D Widzowski
@ast
D Widzowski
@en
D Widzowski
@es
D Widzowski
@nl
Daniel Widzowski
@pl
prefLabel
D Widzowski
@ast
D Widzowski
@en
D Widzowski
@es
D Widzowski
@nl
Daniel Widzowski
@pl
P106
P1153
6602790520
P31
P496
0000-0003-4942-1642